WHO ICTRP trial
Efficacy and Safety of Carica Papaya Leaf Extract Syrup in Thrombocytopenia…
CTRI/2018/03/012792 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2018/03/012792 |
|---|---|
| Public title | Efficacy and Safety of Carica Papaya Leaf Extract Syrup in Thrombocytopenia associated With Dengue Fever, in Paediatric Patients |
| Scientific title | Efficacy and Safety of Carica Papaya Leaf Extract in Dengue Fever with Thromobocytopenia in Paediatric age Group |
| Primary sponsor | Micro Labs Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: null- Thrombocytopenia associated with Dengue fever in Paediatric Patients |
| Interventions | Intervention1: Carica Papaya leaf extract (Caripill) syrup: Participants aged above 1 year and below 5 years were administered with 275 mg / 5 ml of Carica Papaya leaf extract (Caripill) syrup three times a day for 5 days and the… |
| Registration date | Mar 23, 2018 |
| Target size | 280 |
| Secondary IDs | MLL/CARI/02/2017 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: